85-1438-64　［取扱停止］Varicella Zoster Virus, ORF26, Recombinant (aa9-33, 184-208) (VZV) 100ug　V2100-41

特徴

• Varicella-zoster virus (VZV) interacts with cell surface heparan sulfate proteoglycans during virus attachment. VZV-gE is a glycoprotein that plays an active or supportive role in VZV cell membrane fusion. VZV-gE was found to enhance the fusogenic potential of VZV gB.
• The protein contains the VZV-ORF26 immunodominant regions, amino acids: (9-33/184-208).
• Specificity:Immunoreactive with sera of VZV-infected individuals
• Applications:Recombinant VZV-ORF26 Antigen may be used in ELISA and Western Blots, excellent for detection of VZV with minimal specificity problems.
• Storage and Stability:May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：100ug
• Source Antigen：Recombinant, E. coli
• Grade：Highly Purified
• Purity：≥ 95% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified.
• Form：Supplied as a liquid in 25mM Tris-HCl, 1mM EDTA, 50% glycerol.
• EU Commodity Code：30021019
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]